Literature DB >> 25193559

Cardiovascular disease associated with the human immunodeficiency virus: an update.

Thomas S Metkus1, Todd T Brown, Wendy S Post.   

Abstract

OPINION STATEMENT: With the advent of increasingly available antiretroviral therapy (ART), the life expectancy of HIV-infected persons is increasing. As they age, HIV-infected persons have increased propensity to typical diseases of aging including cardiovascular disease and accelerated atherosclerosis. The pathogenesis of HIV-associated atherosclerosis is complex and involves a state of chronic inflammation, exposure to traditional risk factors, and metabolic side effects of ART. Treatment of HIV-associated atherosclerosis should include special attention to drug-drug interactions and is best accomplished by a multidisciplinary team experienced in the care of HIV-infected persons.

Entities:  

Year:  2014        PMID: 25193559     DOI: 10.1007/s11936-014-0346-x

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  63 in total

1.  The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study.

Authors:  M G Law; N Friis-Møller; W M El-Sadr; R Weber; P Reiss; A D'Arminio Monforte; R Thiébaut; L Morfeldt; S De Wit; C Pradier; G Calvo; O Kirk; C A Sabin; A N Phillips; J D Lundgren
Journal:  HIV Med       Date:  2006-05       Impact factor: 3.180

2.  Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.

Authors:  William E Boden; Jeffrey L Probstfield; Todd Anderson; Bernard R Chaitman; Patrice Desvignes-Nickens; Kent Koprowicz; Ruth McBride; Koon Teo; William Weintraub
Journal:  N Engl J Med       Date:  2011-11-15       Impact factor: 91.245

3.  Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study.

Authors:  Esteban Martínez; María Larrousse; Josep M Llibre; Felix Gutiérrez; Maria Saumoy; Antonio Antela; Hernando Knobel; Javier Murillas; Juan Berenguer; Judit Pich; Ignacio Pérez; José M Gatell
Journal:  AIDS       Date:  2010-07-17       Impact factor: 4.177

4.  Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection.

Authors:  Samuel A Bozzette; Christopher F Ake; Henry K Tam; Sophia W Chang; Thomas A Louis
Journal:  N Engl J Med       Date:  2003-02-20       Impact factor: 91.245

5.  Effects of combined exercise training on immunological, physical and biochemical parameters in individuals with HIV/AIDS.

Authors:  Alesandro Garcia; Géssica Alves Fraga; Roberto Carlos Vieira; Carolina Mendes Santos Silva; Joice Cristina Dos Santos Trombeta; James Wilfred Navalta; Jonato Prestes; Fabricio Azevedo Voltarelli
Journal:  J Sports Sci       Date:  2013-11-29       Impact factor: 3.337

6.  HIV infection and the risk of acute myocardial infarction.

Authors:  Matthew S Freiberg; Chung-Chou H Chang; Lewis H Kuller; Melissa Skanderson; Elliott Lowy; Kevin L Kraemer; Adeel A Butt; Matthew Bidwell Goetz; David Leaf; Kris Ann Oursler; David Rimland; Maria Rodriguez Barradas; Sheldon Brown; Cynthia Gibert; Kathy McGinnis; Kristina Crothers; Jason Sico; Heidi Crane; Alberta Warner; Stephen Gottlieb; John Gottdiener; Russell P Tracy; Matthew Budoff; Courtney Watson; Kaku A Armah; Donna Doebler; Kendall Bryant; Amy C Justice
Journal:  JAMA Intern Med       Date:  2013-04-22       Impact factor: 21.873

7.  Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984-2008.

Authors:  Nikolas Wada; Lisa P Jacobson; Mardge Cohen; Audrey French; John Phair; Alvaro Muñoz
Journal:  Am J Epidemiol       Date:  2013-01-03       Impact factor: 4.897

Review 8.  HIV and coronary heart disease: time for a better understanding.

Authors:  Franck Boccara; Sylvie Lang; Catherine Meuleman; Stephane Ederhy; Murielle Mary-Krause; Dominique Costagliola; Jacqueline Capeau; Ariel Cohen
Journal:  J Am Coll Cardiol       Date:  2013-02-05       Impact factor: 24.094

9.  Food insecurity and other poverty indicators among people living with HIV/AIDS: effects on treatment and health outcomes.

Authors:  Seth C Kalichman; Dominica Hernandez; Chauncey Cherry; Moira O Kalichman; Christopher Washington; Tamar Grebler
Journal:  J Community Health       Date:  2014-12

10.  Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study.

Authors:  Signe Westring Worm; Caroline Sabin; Rainer Weber; Peter Reiss; Wafaa El-Sadr; Francois Dabis; Stephane De Wit; Matthew Law; Antonella D'Arminio Monforte; Nina Friis-Møller; Ole Kirk; Eric Fontas; Ian Weller; Andrew Phillips; Jens Lundgren
Journal:  J Infect Dis       Date:  2010-02-01       Impact factor: 5.226

View more
  3 in total

1.  Rosuvastatin Worsens Insulin Resistance in HIV-Infected Adults on Antiretroviral Therapy.

Authors:  Kristine M Erlandson; Ying Jiang; Sara M Debanne; Grace A McComsey
Journal:  Clin Infect Dis       Date:  2015-07-08       Impact factor: 9.079

2.  Immune activation, immunosenescence, and osteoprotegerin as markers of endothelial dysfunction in subclinical HIV-associated atherosclerosis.

Authors:  Alessandra D'Abramo; Maria Antonella Zingaropoli; Alessandra Oliva; Claudia D'Agostino; Samir Al Moghazi; Giulia De Luca; Marco Iannetta; Claudio Maria Mastroianni; Vincenzo Vullo
Journal:  Mediators Inflamm       Date:  2014-10-14       Impact factor: 4.711

3.  Functional capacity and ventilatory efficiency are preserved in well-controlled people living with human immunodeficiency virus/acquired immunodeficiency syndrome.

Authors:  Luís Fernando Deresz; Marlus Karsten; Isadora Faraco Corrêa; Anelise Sonza; Maria Letícia Rodrigues Ikeda; Candissa Silva da Silva; Pedro Dal Lago
Journal:  J Exerc Rehabil       Date:  2018-08-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.